Wall Street Hedge

Sunday, January 17, 2021
Log in
  • Home
  • Nation & Politics
  • Financial News
  • Technology & Research
  • Lifestyle & Health
    • Latest News
      • Business
      • Nature
      • Science
      • World
      • VA Hospitals Are Still Under Investigation for Suspected Drug Thefts

Heron’s upcoming nausea drug was successful in its clinical trial

By Leave a Comment

Heron's upcoming nausea drug was successful in its clinical trial

Heron has had a successful outcome in the third phase of its clinical trial for its upcoming nausea drug, SUSTOL. This means that they are ready to issue another market application to the FDA, in order for the drug to receive approval.

SUSTOL is a strong anti-nausea drug, meant to be used for patients who undergo chemotherapy. In order to test out its potency, SUSTOL was included in a three-drug combination and compared to the standard of care, that is in use at the moment.

The study was conducted on 900 patients, who were administered highly emetogenic chemotherapy medication and then were separated into two separate groups. The first group represented the whiteness group and the subjects included in it received the standard of care drug combination, that consists of ondansetron, fosaprepitant and dexamethason.

The second group was the one that SUSTOL was tested on. The patients from this group were administered SUSTOL, which is granisetron, with an extended release, associated with fosaprepitant and dexamethasone.

The results were in favor of the SUSTOL group, as 67% of the patients included in it responded to the course of medication, compared to the 57% who responded who the standard of care combination.

These results are extremely promising for the new Heron drug. It now has a chance of being included in the treatment of patients undergoing chemotherapy in the future, after it receives its FDA approval.

However, this is going to take quite some time to happen, as the application is expected to be sent to the FDA around mid-2015. Afterwards, it is not certain how much will the FDA take to verify the results of the clinical studies conducted by Heron and eventually decide if this time they will approve SUSTOL.

Heron has previously sent in applications for SUSTOL to the FDA, but they got rejected every time, because their file was in need of additional data.

This time though, it looks like SUSTOL might be ready for its long awaited approval. If the FDA will actually consider that its testing phase is complete, then the new nausea drug will become one of the most effective in this group of medication.
Image Source: smarteranalyst

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Lifestyle & Health

Leave a Reply Cancel reply

You must be logged in to post a comment.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other subscribers

Recent Articles

AXA building in Wiesbaden, Germany.

Insurer AXA To Buy XL Group For $15 Billion

By Leave a Comment

New York Stock Exchange on Wall Street.

Wall Street Comes Out Intact As Global Stock Rise

By Leave a Comment

Ryanair profits are up despite threats of pilot strike.

Ryanair Profits Are Up But A New Pilot Strike May Be Around The Corner

By Leave a Comment

Bitcoin bubble may burst, analysts speculate.

Bitcoin Bubble Shows Signs Of Bursting

By Leave a Comment

One percent amassed 82 percent of the world's fortune last year.

82 Percent Of The World’s Wealth Went To The One Percent In 2017, According To Oxfam Report (Report)

By Leave a Comment

Morgan Stanley will be hit with a $1.25 billion charge as part of the new Republican tax cut.

Morgan Stanley To Be Hit With $1.25 Billion Charge From Republican Tax Reform

By Leave a Comment

General Electric Laboratory

High Demand For Renewable Forces General Electric To Slash 12 Thousand Jobs Worldwide

By Leave a Comment

Cryptocurrency bitcoin coins

Cryptocurrency Is Worth More Than JPMorgan, Bitcoin Raises Concerns

By Leave a Comment

Computer circuit board

Chipmaker Company, Marvell Technology, to Buy its Rival Cavium in $6 billion Deal

By Leave a Comment

Thanksgiving dinner

Thanksgiving Dinner Will Cost Less This Year as Food Gets Cheaper

By Leave a Comment

Doctors in surgery

Vermont Is Preparing New Health Care System

By Leave a Comment

Saudi Arabia’s capital city Riyadh

Saudi Arabia Has Just Bought Huge Stake in Uber

By Leave a Comment

No Agreement Yet on the Trans-Pacific Partnership

By Leave a Comment

Samsung Shareholders Approve Deal Which Sees Lee Family Gain More Control

By Leave a Comment

Related Articles

  • Shaving brush after being dipped into a bowl full of shaving foam

    Strange Sunburn Remedy Goes Viral and Doctors Confirm It Might Actually Work

  • Flight attendant serving coffee and water to the passengers

    Flight Attendants Have a More Elevated Cancer Risk than the Normal Population (Study)

  • Hand lying on the floor next to an empty pill bottle

    British Man Claims a Horror Video Game Caused His Son to Commit Suicide

  • Bud of a cannabis plant with hairy leaves

    FDA Has Approved the First Drug Produced from Cannabis, but It Can’t Go on the Market Yet

  • Colorful tattoo on a person's right leg

    Woman with Weak Immune System Develops Knee Pain After Getting a Leg Tattoo (Study)

  • Teenage girls talking next to a metal fence

    Teenagers Are Laying Off Risky Behaviors, But Don’t Take Good Care of their Health

  • Teaspoon full of sugar

    Toddlers Eat a Lot More Added Sugar than They Should

  • Man eating a cookie and spilling jam on his tie

    Why Do People Become Hangry? Researchers Offer Psychological Explanation (Study)

  • Teddy bear with a crumpled tissue, a vaccine container, and a syringe on it

    You Can Get $3,500 If You Leave Yourself Infected with the Flu at Hotel Influenza

  • Viagra pill placed on a white surface

    Man Sues CVS for Leaking Information on His Viagra Prescription to His Wife

Categories

  • Business
  • Entertainment
  • Financial News
  • Lifestyle & Health
  • Nation & Politics
  • National News
  • Nature
  • Science
  • Technology & Research
  • World

Copyright © 2021 WallStreetHedge.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.